Sign in
4

Changes in Ownership

MoonLake Immunotherapeutics Filed Acc 0001213900-25-084492

Chief Scientific Officer acquired 48,978 shares (conversion)

  • Chief Scientific Officer returned 48,978 shares (to the company)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Reich Kristian Chief Scientific Officer 2025-09-02 Conversion +48,978 202,908 D
Reich Kristian Chief Scientific Officer 2025-09-02 Returned to the company −48,978 35,389 D
Derivatives
Reich Kristian Chief Scientific Officer 2025-01-20 Conversion · Common shares, par value CHF 0.10 per share, of MoonLake AG −1,456 1,052 D
Loading xslF345X05/ownership.xml…